T. Rowe Price Credit Opportunities Comp (S:0P0001A21X)
15.40
-0.05
(-0.35%)
USD |
Oct 31 2024
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
| Maximum Management Fee | Annualized Total Returns Since Inception (Daily) | Alpha (vs Category) (3Y) | Forecasted Dividend Yield |
|---|---|---|---|
| -- | -- | -- | -- |
| Total Market Value (Net) | Beta (vs Category) (3Y) | Max Drawdown (Since Inception) | Fwd Dividend Yield (Long) |
| Upgrade | Upgrade | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | US Fixed Income |
| YCharts Benchmark | Bloomberg US Aggregate (^BBUSATR) |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| Bloomberg US HY 2% Issuer Cap TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Michael Della Vedova | 10.42 yrs |
| Paul Massaro | 10.42 yrs |
| Rodney Rayburn | 9.33 yrs |
| Jason Bauer | 4.68 yrs |
| David Yatzeck | 0.60 yrs |
Annual Total Returns Versus Peers
As of November 14, 2024.
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | -- | -- | -- |
| Stock | -- | -- | -- |
| Bond | -- | -- | -- |
| Convertible | -- | -- | -- |
| Preferred | -- | -- | -- |
| Other | -- | -- | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
T. Rowe Price Government Reserve
|
2.87% | -- | -- |
|
Vistra Corp 9%
|
2.82% | -- | -- |
|
Talen Energy Supply LLC 9%
|
2.37% | -- | -- |
|
Alliant Inc Services Pfd Pp - 2173-01-01
|
1.49% | -- | -- |
|
Truist Insurance Holdings LLC & Panther Co-Issuer Inc. 7%
|
1.34% | -- | -- |
|
Vistra Corp 8%
|
1.32% | -- | -- |
|
Service Properties Trust 9%
|
1.21% | -- | -- |
|
Rivian Holdings Llc / Rivian Llc / Rivian Automotive Llc 11%
|
1.21% | -- | -- |
|
Jones Deslauriers Insurance Management Inc. 11%
|
1.18% | -- | -- |
|
Medline Borrower LLP / Medline Co-Issuer Inc. 6%
|
1.17% | -- | -- |
Fees & Availability
| Fees | |
| Negotiable Fee | No |
| Administrative Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Trustee Fee | -- |
| Purchase Details | |
| Open to New Investors | No |
| Open to Existing Investors | No |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | US Fixed Income |
| YCharts Benchmark | Bloomberg US Aggregate (^BBUSATR) |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| Bloomberg US HY 2% Issuer Cap TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Michael Della Vedova | 10.42 yrs |
| Paul Massaro | 10.42 yrs |
| Rodney Rayburn | 9.33 yrs |
| Jason Bauer | 4.68 yrs |
| David Yatzeck | 0.60 yrs |
Fundamentals
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Forecasted Dividend Yield | -- |
| Forecasted PE Ratio | -- |
| Forecasted Price to Sales Ratio | -- |
| Forecasted Price to Book Ratio | -- |
| Bond | |
| Current Yield | -- |
| Yield to Maturity | -- |
| Effective Duration | -- |
| Average Coupon | -- |
| Average Credit Score | -- |
| Average Price | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |